SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Investigative Dermatology

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jid.2011.239PMID 21850018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression

  2011cited by this paper
• Lost in migration

  2010cited by this paper
• PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.

  2010cited by this paper
• Dynamic interplay between the collagen scaffold and tumor evolution.

  2010cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Matrix crosslinking forces tumor progression by enhancing integrin signaling.

  2009cited by this paper
• Post-Translational Regulation of Cathepsin B, but not of Other Cysteine Cathepsins, Contributes to Increased Glioblastoma Cell Invasiveness In Vitro

  2009cited by this paper
• The morphological and molecular features of the epithelial-to-mesenchymal transition

  2009cited by this paper
• Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

  2009cited by this paper
• The Copper Binding Domain of SPARC Mediates Cell Survival in Vitro via Interaction with Integrin β1 and Activation of Integrin-linked Kinase*

  2008cited by this paper
• Collagen I–mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1

  2008cited by this paper
• Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

  2008cited by this paper
• The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

  2008cited by this paper
• The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

  2008cited by this paper
• Mapping of SPARC/BM-40/Osteonectin-binding Sites on Fibrillar Collagens*

  2008cited by this paper
• IFATS Collection: Combinatorial Peptides Identify α5β1 Integrin as a Receptor for the Matricellular Protein SPARC on Adipose Stromal Cells

  2008cited by this paper
• Growth control by intracellular tension and extracellular stiffness.

  2008cited by this paper
• Proteomic analysis identified N‐cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells

  2007cited by this paper
• Osteonectin downregulates E‐cadherin, induces Osteopontin and Focal adhesion kinase activity stimulating an invasive melanoma phenotype

  2007cited by this paper
• Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial–mesenchymal transition

  2007cited by this paper
• Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-β1-signaling and upregulation of cathepsin B

  2007cited by this paper
• SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.

  2007cited by this paper
• Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases

  2007cited by this paper
• SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.

  2006cited by this paper
• Cysteine cathepsins: multifunctional enzymes in cancer

  2006cited by this paper
• CellProfiler: image analysis software for identifying and quantifying cell phenotypes

  2006cited by this paper
• Contact of high‐invasive, but not low‐invasive, melanoma cells to native collagen I induces the release of mature cathepsin B

  2006cited by this paper
• Linear Mixed Models: A Practical Guide Using Statistical Software

  2006cited by this paper
• Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.

  2006cited by this paper
• The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.

  2005cited by this paper
• Identifying the SPARC binding sites on collagen I and procollagen I by atomic force microscopy.

  2005cited by this paper
• The Amyloid-β Peptide Suppresses Transforming Growth Factor-β1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells*

  2005cited by this paper
• Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity.

  2005cited by this paper
• Management of cutaneous melanoma.

  2004cited by this paper
• SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength.

  2003cited by this paper
• Pericellular cathepsin B and malignant progression

  2003cited by this paper
• PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification

  2003cited by this paper
• Erratum: PANTHER: A browsable database of gene products organized by biological function, using curated protein family and subfamily classification (Nucleic Acids Research (2003) vol. 31 (334-341))

  2003cited by this paper
• PANTHER: a library of protein families and subfamilies indexed by function.

  2003cited by this paper
• SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

  2003cited by this paper
• Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

  2002cited by this paper
• Inhibition of Transforming Growth Factor (TGF)- 1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF- Type I Receptor Kinase Activity: SB-431542

  2002cited by this paper
• Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.

  2002cited by this paper
• Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B*

  2002cited by this paper
• SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

  2001cited by this paper
• SPARC, a matricellular protein: at the crossroads of cell-matrix communication.

  2001cited by this paper
• Dynamics of intercellular communication during melanoma development.

  2000cited by this paper
• Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.

  2000cited by this paper
• Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.

  1999cited by this paper
• Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass.

  1999cited by this paper
• Increased SPARC expression promotes U87 glioblastoma invasion in vitro

  1999cited by this paper
• SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial Cells*

  1999cited by this paper
• The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

  1997cited by this paper
• Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

  1997cited by this paper
• Limited Cleavage of Extracellular Matrix Protein BM-40 by Matrix Metalloproteinases Increases Its Affinity for Collagens*

  1997cited by this paper
• Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.

  1995cited by this paper
• Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase.

  1994cited by this paper
• TGF‐β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors

  1994cited by this paper
• Epithelial-mesenchymal Transition as a Major Determinant a High-throughput Study in Melanoma Identifies Updated Version Material Supplementary Cited Articles Citing Articles E-mail Alerts a High-throughput Study in Melanoma Identifies Epithelial- Mesenchymal Transition as a Major Determinant of Meta

  year unknowncited by this paper

• The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.

  2026cites this paper
• Cathepsin B Mediates HDAC Inhibitor-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

  2026cites this paper
• Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression

  2025cites this paper
• The mycotoxin Beauvericin is an uncompetitive inhibitor of Cathepsin B

  2025cites this paper
• Circadian rhythm related genes identified through tumorigenesis and immune infiltration-guided strategies as predictors of prognosis, immunotherapy response, and candidate drugs in skin cutaneous malignant melanoma

  2025cites this paper
• GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs

  2024cites this paper
• Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations

  2024cites this paper
• Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy

  2024cites this paper
• Carnosic acid inhibits integrin expression and prevents pulmonary metastasis of melanoma.

  2024cites this paper
• SPARC: a potential target for functional nanomaterials and drugs

  2023cites this paper
• A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer

  2023cites this paper
• Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells

  2022cites this paper
• Marine Collagen: Promising Biomaterial in Delivery of Therapeutics for Cancer Therapy

  2022cites this paper
• Head-to-head comparison of CCN4, DNMT3A, PTPN11, and SPARC as suppressors of anti-tumor immunity

  2022cites this paper
• In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer

  2022cites this paper
• SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells

  2022cites this paper
• Effects of SPARC and Possible Receptors on Colon Cancer Cell Line

  2022cites this paper
• Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients

  2022cites this paper
• Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix

  2022cites this paper
• Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance

  2022cites this paper
• Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells

  2021cites this paper
• Vemurafenib drives EMT gene expression in BRAFi-resistant BRAFV600E/NRASQ61K melanoma enhancing tumor growth and metastasis in a bioluminescent murine model.

  2021cites this paper
• Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma

  2021cites this paper
• FAM3C: an emerging biomarker and potential therapeutic target for cancer.

  2021cites this paper
• Analysis of Melanoma Secretome for Factors That Directly Disrupt the Barrier Integrity of Brain Endothelial Cells

  2020cites this paper
• A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression

  2020cites this paper
• Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins

  2020cites this paper
• Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location

  2019cites this paper
• Cathepsins: Potent regulators in carcinogenesis.

  2019cites this paper
• The role of collagen in cancer: from bench to bedside

  2019cites this paper
• SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis

  2019cites this paper
• SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.

  2019cites this paper
• SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma

  2018cites this paper
• Role of the extracellular matrix in cancer‐associated epithelial to mesenchymal transition phenomenon

  2018cites this paper
• SPARC acts as a mediator of TGF‐&bgr;1 in promoting epithelial‐to‐mesenchymal transition in A549 and H1299 lung cancer cells

  2018cites this paper
• Implication of Integrin α2β1 in Proliferation and Invasion of Human Breast Carcinoma and Melanoma Cells: Noncanonical Function of Akt Protein Kinase

  2018cites this paper
• Proteomic profiling of the cancer cell secretome: informing clinical research

  2017cites this paper
• Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition

  2016cites this paper
• Role of SPARC in Cancer; Friend or Foe

  2016cites this paper
• SPARC Controls Melanoma Cell Plasticity through Rac1

  2015cites this paper
• Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion

  2015cites this paper
• SCD5‐induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B

  2015cites this paper
• Extracellular matrix in obesity – cancer interactions

  2015cites this paper
• Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma

  2015cites this paper
• Cancer-associated fibroblasts in pancreatic adenocarcinoma.

  2015cites this paper
• Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells

  2015cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis

  2014cites this paper
• Nones, K. et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-

  2014cites this paper
• SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target.

  2014cites this paper
• Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma

  2014cites this paper
• Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling

  2014cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.

  2014cites this paper
• Cathepsin B: Multiple roles in cancer

  2014cites this paper
• Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction

  2014cites this paper
• Cathepsin B Inhibitors for Targeted Cancer Therapy

  2014cites this paper
• The wound healing, chronic fibrosis, and cancer progression triad.

  2014cites this paper
• Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

  2013cites this paper
• Basal/HER2 breast carcinomas

  2013cites this paper
• Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment.

  2013cites this paper
• Cathepsin B as a cancer target

  2013cites this paper
• Dissection of the Human Multipotent Adult Progenitor Cell Secretome by Proteomic Analysis

  2013cites this paper
• The secretome signature of colon cancer cell lines

  2013cites this paper
• Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma

  2013cites this paper
• Osteonectin (SPARC) Is a Key Regulator of Malignant Pleural Mesothelioma

  2013cites this paper
• Secreted Protein Acidic and Rich in Cysteine (Sparc) in Cancer

  2013cites this paper
• Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis

  2012cites this paper
• Integrin β4 Regulates SPARC Protein to Promote Invasion*

  2012cites this paper
• Microenvironment and tumor progression of melanoma: New therapeutic prospectives

  2012cites this paper
• The Function of SPARC as a Mediator of Fibrosis

  2012cites this paper
• The multi-reference contrast method: Facilitating set enrichment analysis

  2012cites this paper